Concepedia

Melanoma Regression

Melanoma Regression is a histopathological phenomenon characterized by the partial or complete immune-mediated destruction of primary melanoma cells, leading to fibrosis, inflammation, and architectural remodeling that obscures the original tumor, distinguished from non-regressed melanomas by the absence of viable neoplastic melanocytes in the affected regions.

419

Publications

26.4K

Citations

2.5K

Authors

697

Institutions

Publications per year

2017–2026

81

Parents

Publications

419

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

Claudio G. Clemente, Martín C. Mihm, Rosaria Bufalino et al. · Cancer · 1996 · 1.1K citations · Full text

, , +16

PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors

Alena Gros, Paul F. Robbins, Xin Yao et al. · Journal of Clinical Investigation · 2014 · 1.1K citations · Full text

, , +17

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas van Baren, P. Weynants et al. · International Journal of Cancer · 1999 · 786 citations

, , +17

Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis

Dan A. Erkes, Weijia Cai, Ileine M. Sanchez et al. · Cancer Discovery · 2019 · 485 citations · Full text

, , +17

High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer

Michael T. Lotze · JAMA · 1986 · 459 citations

, , +17

1–5 of 419

Authors

2.5K

  1. PQ
    Pietro Quaglino

    University of Turin, Italy

    10 publications · 438 citations

    10

    h-index

  2. SR
    Simone Ribero

    University of Turin, Italy

    9 publications · 311 citations

    9

    h-index

  3. ET
    Edward T. Creagan

    Mayo Clinic, United States

    8 publications · 465 citations

    8

    h-index

  4. VH
    Vratislav Horák

    Czech Academy of Sciences, Institute of Animal Physiology and Genetics, Czechia

    8 publications · 346 citations

    8

    h-index

  5. SO
    Simona Osella‐Abate

    University of Turin, Italy

    7 publications · 244 citations

    7

    h-index

1–5 of 2.5K

Institutions

697

  1. Royal Prince Alfred Hospital

    Sydney, Australia

    15 h-index

    44 publications

    4.2K citations

  2. The University of Texas MD Anderson Cancer Center

    Houston, United States

    14 h-index

    74 publications

    10.3K citations

  3. Massachusetts General Hospital

    Boston, United States

    13 h-index

    61 publications

    10.3K citations

  4. The University of Sydney

    Sydney, Australia

    12 h-index

    57 publications

    4.6K citations

  5. National Institutes of Health

    Bethesda, United States

    10 h-index

    50 publications

    21.8K citations

  6. Harvard University

    Cambridge, United States

    10 h-index

    52 publications

    5.3K citations

  7. University of Turin

    Turin, Italy

    9 h-index

    59 publications

    2.2K citations

  8. National Cancer Institute

    Bethesda, United States

    9 h-index

    47 publications

    4.1K citations

1–8 of 697

Venues

  1. PubMed

    Repository · 38 publications · 1.5K citations

    20

    h-index

  2. Cancer

    20 publications · 2.9K citations

    19

    h-index

  3. Melanoma Research

    19 publications · 626 citations

    17

    h-index

  4. Journal of Clinical Oncology

    15 publications · 1.4K citations

    13

    h-index

  5. Archives of Dermatology

    11 publications · 737 citations

    11

    h-index

1–5